Stratec SE (STSEY)
OTC Markets OTCPK · USD · Healthcare · Medical Devices
$5.51 (+0.00%) as of
Key statistics
- Market cap
- 334.90M
- EPS (TTM)
- -0.06
- Dividend yield
- 2.55%
- 52-week range
- 5.00 – 6.70
- Beta
- 0.85
- Revenue (TTM)
- 244.81M
- Profit margin
- -0.16%
- Volume
- 100.00
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Birkenfeld, Germany
- Employees
- 1,383
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.